4//SEC Filing
LAROSA JOSEPH J 4
Accession 0001968202-24-000096
CIK 0000872589other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:02 PM ET
Size
6.1 KB
Accession
0001968202-24-000096
Insider Transaction Report
Form 4
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
- Sale
Common Stock
2024-05-21$994.90/sh−1,865$1,855,489→ 34,678 total
Holdings
- 371(indirect: By 401(k))
Common Stock
- 3,367(indirect: 2022 GRAT)
Common Stock
Footnotes (1)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2024.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001238303
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:02 PM ET
- Size
- 6.1 KB